Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Tropical fish study offers insight into MS
Findings could have implications for human medicine

Insights gained from a study of tropical fish could improve our understanding of the nervous system, and even enhance the treatment of human conditions such as multiple sclerosis (MS).

By studying zebrafish, scientists at the University of Edinburgh uncovered vital clues about the production of myelin - a fatty sheath that insulates and protects the nerve fibres.

As myelin allows nerve impulses to be transmitted quickly, it is essential for good health. When it breaks down and is not repaired properly, it can lead to the debilitating symptoms of MS.

Zebrafish were used in the study as they share more than 80 per cent of the genes linked to human diseases, and exhibit very similar drug responses to humans. As young zebrafish are transparent, researchers were able to view their living nervous system without invasive surgery.

As a result of the study, scientists were able to quantify the time frame for developing myelin for the first time.

The findings demonstrate that the individual cells in the brain and central nervous system only have a matter of hours in which to generate the protective coating.

Following this, the team at Edinburgh are now investigating the ways in which gene manipulation and drugs could promote myelin generation in zebrafish.

Researcher at the university, Dr David Lyons, said: "To enhance myelin repair, we will need to improve either their ability to make myelin during the short time in which they have to do this, or find a way to allow them to produce myelin for a longer period of time."

The study, which has been published in Developmental Cell, offers hope for future treatments of myelin-related disorders in humans.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.